The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Amazed?? Really ?? Don't be. No-one will know Moon's strategy for screwing investors better than this fellow. He understands that this share will never be allowed to increase. Strategy = Increase sales. Ignore profit. Issue more shares when further cash is needed. So dilute share value. Expand company . Justify fat cat salary.
This Share Value is going nowhere.
Very good question, and I am amazed that wasn't carried out as pat of the trial . Why on earth did they only test against a known penetrative treatment like dermasys? I would suggest that if they DID test against a genuine inert placebo they ought to make those results known immediately.
Agreed Taff. I find the market response to these results totally baffling. Who cares if MED was a blinding success or not if we've stumbled upon something that does the same thing but quicker and with less side effects. Amazing. Definitely a time to top up I believe.
My thoughts exactly. It's basically saying that MED works but a comparison with just Dermasys didn't show up a big difference because Dermasys works too ! This has been a clear unexpected outcome and a huge benefit. I think the market has completely mis-interpreted the results of this trial probably not helped by the way the RNS was written. I've a suspicion that may have been deliberate so those in the know can but cheaper. Watch the jump after the pod-cast at mid-day.
Clear top up opportunity for me.
If anyone thinks that this will be anything less than £4 ps in a year or two's time then you have no idea just how desperate NHS's are, around Europe at least, to reduce their treatment budgets. If as expected this can augment / replace viagra as an effective ED treatment goodness knows what the savings will be, hence the demand. Potential licencees will be well aware of that, even if investors are not - yet.
I was about to construct a posting on the above topic but then came accross this recent posting that says it all anyway, so apologies for the cut and paste job...."Barder has a huge reason for getting the company to a successful sale as he and his family must be interested in around 25% of the shares in the Company, indeed his father in law Mr RA Lamb and his investment company has 9.17% alone, and Barder has potentially lucrative options as well.
Sure mistakes have been made, some statements prematurely issued, and time has passed, but we have a product which is needed, serves a worldwide market, and is potentially hugely profitable. Phase three trials if sufficiently successful will open doors and start the recognition of the Companies true worth.
Mention has been made that we are a one product company - no! Although not in the spotlight we have another Item which has huge potential, our pain relief gel and applicator, also what about the CB Derma cooperation re Cannabidiol - that could serve a very large market.
In my (humble) opinion we have a driven business with a good variety of products and a very large return for the faithful. Yes I have had shares in FUM for years so could be termed a ramper, however I only write to point out what anyone else could have discovered, and yes it could all go t*** up but with the high possibility of phase three coming good and other products to come through I’m not selling any of my significant accumulation of shares for today’s pennies.I find the continuing criticism of Barder’s concern for FUM rather baffling! He has a huge reason for getting the company to a successful sale as he and his family must be interested in around 25% of the shares in the Company, indeed his father in law Mr RA Lamb and his investment company has 9.17% alone, and Barder has potentially lucrative options as well.
Sure mistakes have been made, some statements prematurely issued, and time has passed, but we have a product which is needed, serves a worldwide market, and is potentially hugely profitable. Phase three trials if sufficiently successful will open doors and start the recognition of the Companies true worth.
Mention has been made that we are a one product company - no! Although not in the spotlight we have another Item which has huge potential, our pain relief gel and applicator, also what about the CB Derma cooperation re Cannabidiol - that could serve a very large market.
In my (humble) opinion we have a driven business with a good variety of products and a very large return for the faithful. Yes I have had shares in FUM for years so could be termed a ramper, however I only write to point out what anyone else could have discovered, and yes it could all go t*** up but with the high possibility of phase three coming good and other products to come through I’m not selling any of my significant accumulation of shares.
More options. More dilution. Disgusting. Do they really think the comment "Including share price appreciation" is going to convince anyone that the options are properly dependent on performance!!?? FFS this really is insulting. If you want to convince shareholders this is anything but a crock of shiyte provide details of PRECISELY what the pigs have to do to earn more feed !!!!
Huge opportunity now! Has to be a multi bagger at this bargain price !
Fantastic News of the successful Launch ! That's all our Capital Costs behind us now. Cash Cow from now on in. Come on you AVN Sales folks lets see those numbers flow ! Recruitment drive shiould begin to bear fruit now folks. Debt!?? What debt!!?? I would expect to see that pesky term swallowed up by the output from our new super-enhanced sales teams !!!
Onward and Upward !!!
Why on earth is the Launch Date, together with drum roll's and enhanced publicity , not the subject of an incredibly positive RNS ?